|
|
|
books
| book details |
Alzheimer's Disease Drug Development: Research and Development Ecosystem
Edited by Jeffrey Cummings, Edited by Jefferson Kinney, Edited by Howard Fillit
|
|
This book is currently unavailable. Enquire to check if we can source a used copy
|
| book description |
Alzheimer's Disease (AD) is a growing global public health challenge. The development of new therapies is urgently needed, and a complex ecosystem of organizations has grown to facilitate AD drug discovery and development. Masterfully collating information on the drug development ecosystem, this book emphasizes the contributions of each aspect in the pipeline with a uniform approach to chapters, enabling readers to access relevant information quickly. Topics covered include the use of non-clinical laboratory studies, biomarker development, artificial intelligence, design and management of clinical trials, and funding and financing models. Also discussed is the critical role of advocacy fundraising for drug development. With the approval of aducanumab, the function of the ecosystem has become apparent. This is a definitive overview of how the ecosystem works in transferring an AD drug from its discovery in the laboratory through clinical trial testing to regulatory review and eventual marketing.
| product details |
Normally shipped |
Publisher | Cambridge University Press (Virtual Publishing)
Published date | 3 Mar 2022
Language |
Format | Digital download and online
Pages | 0
Dimensions | 0 x 0 x 0mm (L x W x H)
Weight | 0g
ISBN | 978-1-1089-7575-9
Readership Age |
BISAC | medical / neurology
| other options |
|
|
|
To view the items in your trolley please sign in.
| sign in |
|
|
|
| specials |
|
|
|
Mason Coile
Paperback / softback
224 pages
was: R 520.95
now: R 468.95
|
A terrifying locked-room mystery set in a remote outpost on Mars.
|
An epic love story with the pulse of a thriller that asks: what would you risk for a second chance at first love?
|
|
|
|
|
